CLINICAL_TRIALS
trial_result
· 2021-02-12
Clinical Trial Update: Title: Evaluation of a Novel PET Radioligand for Phosphodiesterase-4D (PDE4D) [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial evaluating a novel PET radioligand targeting PDE4D for depression; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Mental Health (NIMH) | Conditions: Depression | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-02-12